EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Prospective Observational Study

Sonali B. Rode, Keerti Sopanrao Jogdand, Harsh Vidyadhar Salankar, Bhargav Koyani, Snehal Himmatlal Shah, Jitendra Patel

Journal of Pharmacy and Bioallied Sciences · 2026-10 · 18 (4) · 362-364

DOI: 10.4103/jpbs.jpbs_281_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Bioallied Sciences, online erschienen am 17.11.2026. Verfasst von Sonali B. Rode und 5 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A BSTRACT Background: Proton pump inhibitors (PPIs) are widely prescribed and generally well tolerated, yet unnecessary or prolonged exposure may increase the likelihood of adverse drug reactions (ADRs).

Objective

To evaluate the pattern, frequency, severity, and clinical predictors of ADRs among adults receiving PPIs.

Methods

In this prospective observational model study, 240 adults receiving pantoprazole, omeprazole, esomeprazole, or rabeprazole were followed for 6 months. Suspected ADRs were assessed clinically and, when appropriate, by laboratory testing; causality and severity were categorized using standard pharmacovigilance scales.

Results

The mean age was 48.6 ± 15.2 years and 55.0% were men. Fifty-two participants (21.7%) experienced at least one suspected ADR, accounting for 61 events. Headache (18.0% of events), diarrhea (14.8%), abdominal discomfort (13.1%), nausea (11.5%), and constipation (9.8%) were most frequent. Five patients (2.1%) developed hypomagnesemia. ADRs were more common in patients aged ≥60 years than in younger adults (31.6% vs. 17.1%, P = 0.009), in those receiving PPIs for >6 months (35.6% vs. 13.7%, P < 0.001), and in those with polypharmacy (33.3% vs. 16.0%, P = 0.002). ADR rates did not differ significantly among individual PPIs ( P = 0.97). Most events were mild (70.5%) or moderate (27.9%); one severe event occurred and no fatal event was observed.

Conclusion

Suspected PPI-related ADRs were predominantly nonserious, but longer exposure, older age, and polypharmacy were associated with higher occurrence.

Zitieren

APA

Rode, S. B., Jogdand, K. S., Salankar, H. V., Koyani, B., Shah, S. H., & Patel, J. (2026). Evaluation of Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Prospective Observational Study. Journal of Pharmacy and Bioallied Sciences, 18(4), 362-364. https://doi.org/10.4103/jpbs.jpbs_281_26

Vancouver

Rode SB, Jogdand KS, Salankar HV, Koyani B, Shah SH, Patel J. Evaluation of Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Prospective Observational Study. Journal of Pharmacy and Bioallied Sciences. 2026;18(4):362-364. doi:10.4103/jpbs.jpbs_281_26

BibTeX
@article{Rode2026,
  author = {Rode, Sonali B. and Jogdand, Keerti Sopanrao and Salankar, Harsh Vidyadhar and Koyani, Bhargav and Shah, Snehal Himmatlal and Patel, Jitendra},
  title = {Evaluation of Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Prospective Observational Study},
  journal = {Journal of Pharmacy and Bioallied Sciences},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {362--364},
  doi = {10.4103/jpbs.jpbs_281_26}
}
Kostenlos starten →